Expert Interview
Discussing the standard of care and the recent label expansion of Prevymis by Merck Pharmaceuticals for CMV prophylaxis after kidney transplant in Donor CMV-seropositive/Recipient CMV-seronegative patients.
Ticker(s): MRKInstitution: Hennepin Healthcare
- Nephrology specialist dedicated to deliver quality care to patients with kidney disease.
- Main clinical focus is kidney transplant.
- Experienced in general nephrology, including chronic kidney disease related to hypertension and diabetic complications, acid/base abnormalities and fluid and electrolyte balance.
- Also cares for patients on hemodialysis and peritoneal dialysis.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
